Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


18.09.2017

2 Am J Med Genet B Neuropsychiatr Genet
3 Can J Psychiatry
1 J Clin Psychopharmacol
1 Neuropsychopharmacology
1 PLoS One
2 Psychiatry Res
2 Psychol Med
10 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Med Genet B Neuropsychiatr Genet

  1. KOS MZ, Carless MA, Peralta J, Curran JE, et al
    Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance.
    Am J Med Genet B Neuropsychiatr Genet. 2017 Sep 13. doi: 10.1002/ajmg.b.32597.
    PubMed     Text format     Abstract available

  2. BUSTAMANTE ML, Herrera L, Gaspar PA, Nieto R, et al
    Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype.
    Am J Med Genet B Neuropsychiatr Genet. 2017;174:663-670.
    PubMed     Text format     Abstract available


    Can J Psychiatry

  3. CROCKFORD D, Addington D
    Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.
    Can J Psychiatry. 2017;62:624-634.
    PubMed     Text format     Abstract available

  4. LECOMTE T, Abidi S, Garcia-Ortega I, Mian I, et al
    Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Children and Youth.
    Can J Psychiatry. 2017;62:648-655.
    PubMed     Text format     Abstract available

  5. ADDINGTON D, Anderson E, Kelly M, Lesage A, et al
    Canadian Practice Guidelines for Comprehensive Community Treatment for Schizophrenia and Schizophrenia Spectrum Disorders.
    Can J Psychiatry. 2017;62:662-672.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  6. HOJLUND M, Munk-Jorgensen P
    Differences in Antipsychotic Prescriptions Between Centers in Young Outpatients With Schizophrenia.
    J Clin Psychopharmacol. 2017 Sep 7. doi: 10.1097/JCP.0000000000000779.
    PubMed     Text format    


    Neuropsychopharmacology

  7. RAMSAY IS, Fryer S, Boos A, Roach BJ, et al
    Response to Targeted Cognitive Training Correlates with Change in Thalamic Volume in a Randomized Trial for Early Schizophrenia.
    Neuropsychopharmacology. 2017 Sep 12. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    PLoS One

  8. PINSONNEAULT JK, Frater JT, Kompa B, Mascarenhas R, et al
    Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traits.
    PLoS One. 2017;12:e0179020.
    PubMed     Text format     Abstract available


    Psychiatry Res

  9. WU C, Dagg P, Molgat C
    Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(17)30592.
    PubMed     Text format     Abstract available

  10. ANDERSON AE, Mansolf M, Reise SP, Savitz A, et al
    Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder.
    Psychiatry Res. 2017 Aug 16. pii: S0165-1781(16)31411.
    PubMed     Text format     Abstract available


    Psychol Med

  11. CULBRETH AJ, Moran EK, Barch DM
    Effort-cost decision-making in psychosis and depression: could a similar behavioral deficit arise from disparate psychological and neural mechanisms?
    Psychol Med. 2017 Sep 11:1-16. doi: 10.1017/S0033291717002525.
    PubMed     Text format     Abstract available

  12. SCHULTZE-LUTTER F, Michel C, Ruhrmann S, Schimmelmann BG, et al
    Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community.
    Psychol Med. 2017 Sep 11:1-15. doi: 10.1017/S0033291717002586.
    PubMed     Text format     Abstract available


    Schizophr Res

  13. MOLINA V, Bachiller A, Gomez-Pilar J, Lubeiro A, et al
    Deficit of entropy modulation of the EEG in schizophrenia associated to cognitive performance and symptoms. A replication study.
    Schizophr Res. 2017 Sep 5. pii: S0920-9964(17)30533.
    PubMed     Text format     Abstract available

  14. CIHAKOVA D, Eaton WW, Talor MV, Harkus UH, et al
    Gliadin-related antibodies in schizophrenia.
    Schizophr Res. 2017 Sep 5. pii: S0920-9964(17)30527.
    PubMed     Text format    

  15. HO RWH, Chang WC, Kwong VWY, Lau ESK, et al
    Prediction of self-stigma in early psychosis: 3-Year follow-up of the randomized-controlled trial on extended early intervention.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30544.
    PubMed     Text format     Abstract available

  16. WAMPERS M, Schrauwen S, De Hert M, Gielen L, et al
    Patients with psychosis struggle with scalar implicatures.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30529.
    PubMed     Text format     Abstract available

  17. NORMAN RMG, MacDougall A, Manchanda R, Harricharan R, et al
    An examination of components of recovery after five years of treatment in an early intervention program for psychosis.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30531.
    PubMed     Text format     Abstract available

  18. JOAQUIM HPG, Zanetti MV, Serpa MH, Van de Bilt MT, et al
    Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30538.
    PubMed     Text format     Abstract available

  19. FOND G, Boyer L, Andrianarisoa M, Godin O, et al
    Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30534.
    PubMed     Text format     Abstract available

  20. CUESTA MJ, Garcia de Jalon E, Campos MS, Moreno-Izco L, et al
    Motor abnormalities in first-episode psychosis patients and long-term psychosocial functioning.
    Schizophr Res. 2017 Sep 7. pii: S0920-9964(17)30526.
    PubMed     Text format     Abstract available

  21. SELVARAJ S, Bloomfield PS, Cao B, Veronese M, et al
    Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.
    Schizophr Res. 2017 Sep 8. pii: S0920-9964(17)30539.
    PubMed     Text format     Abstract available

  22. JOHANSSON M, Hjarthag F, Helldin L
    What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study.
    Schizophr Res. 2017 Sep 9. pii: S0920-9964(17)30548.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: